"With this closure, the company has assumed responsibility for the product and will commence shipments of the product in the market shortly," DRL said.

City-based drugmaker Dr Reddy’s Laboratories has acquired Habitrol brand, a nicotine replacement therapy transdermal patch, from NovartisBSE -0.74 % Consumer Health Inc.

According to a statement issued by the drug major, the acquisition of Habitrol brand (an over-the-counter nicotine replacement therapy transdermal patch) from Novartis Consumer Health Inc was done following issuance of the proposed consent order from the US Federal by TotalPlu ..